US 10626372
Methods and compositions for inducing hematopoietic cell differentiation
granted A61PA61P37/02
Quick answer
US patent 10626372 (Methods and compositions for inducing hematopoietic cell differentiation) held by Fate Therapeutics, Inc. expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P37/02